Search results
Results from the WOW.Com Content Network
Concurrent with the Impax merger, Amneal acquired Gemini Laboratories for $117 million, including Unithroid, Gemini's lead product for treating hypothyroidism. [ 10 ] In December 2019, Amneal announced it had entered into an agreement to acquire a majority interest in AvKARE, a private label provider of generic pharmaceuticals in the US federal ...
A bioequivalency profile comparison of extended-release bupropion as produced by Impax Laboratories for Teva and Biovail for GlaxoSmithKline. Note: The generic drug illustrated in this graphic was not affected by the FDA's 300 mg recall and is still available in the United States as of April 2013. [1] [2] Date: 28 April 2013: Source: Own work ...
Impax may refer to: IMPAX (software), ... Impax Environmental Markets, a British company; Impax Laboratories, an American company This page was last edited on ...
Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and ...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
A bioequivalency profile comparison of 150 mg extended-release bupropion as produced by Impax Laboratories for Teva and Biovail for GlaxoSmithKline. Bioequivalence is a term in pharmacokinetics used to assess the expected in vivo biological equivalence of two proprietary preparations of a drug. If two products are said to be bioequivalent it ...
Impax Laboratories is now in the hunt for a new chief executive. The company announced that the man currently occupying that position, Larry Hsu, is to retire. He will remain with the company in ...